Bupivacaine and Localised infection - a phase IV clinical study of FDA data
Summary:
Localised infection is found among people who take Bupivacaine, especially for people who are male, 60+ old.
The phase IV clinical study analyzes which people take Bupivacaine and have Localised infection. It is created by eHealthMe based on reports of 11,327 people who have side effects when taking Bupivacaine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
11,327 people reported to have side effects when taking Bupivacaine.
Among them, 7 people (0.06%) have Localised infection.
What is Bupivacaine?
Bupivacaine has active ingredients of bupivacaine hydrochloride. eHealthMe is studying from 11,367 Bupivacaine users for its effectiveness, alternative drugs and more.
What is Localised infection?
Localised infection (infection at the single location) is found to be associated with 1,335 drugs and 810 conditions by eHealthMe.
Number of Bupivacaine and Localised infection reports submitted per year:
Gender of people who have Localised infection when taking Bupivacaine *:
- female: 42.86 %
- male: 57.14 %
Age of people who have Localised infection when taking Bupivacaine *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 14.29 %
- 60+: 85.71 %
Common drugs people take besides Bupivacaine *:
- Ondansetron: 3 people, 42.86%
- Pantoprazole: 3 people, 42.86%
- Cefazolin: 3 people, 42.86%
- Veletri: 3 people, 42.86%
- Opsumit: 3 people, 42.86%
- Calcium: 2 people, 28.57%
- Lipitor: 2 people, 28.57%
- Androgel: 1 person, 14.29%
- Klor-Con M20: 1 person, 14.29%
- Advair Hfa: 1 person, 14.29%
Common side effects people have besides Localised infection *:
- Nausea (feeling of having an urge to vomit): 4 people, 57.14%
- Pain: 4 people, 57.14%
- Abdominal Pain: 3 people, 42.86%
- Alanine Aminotransferase Increased: 3 people, 42.86%
- Breathing Difficulty: 3 people, 42.86%
- Chest Pain: 3 people, 42.86%
- Diarrhea: 3 people, 42.86%
- Fatigue (feeling of tiredness): 3 people, 42.86%
- Gallbladder Disease: 3 people, 42.86%
- Gallstones (stone formation by bile component): 3 people, 42.86%
Common conditions people have *:
- Pulmonary Hypertension (increase in blood pressure in the lung artery): 2 people, 28.57%
- Pain: 2 people, 28.57%
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 14.29%
- Post Laminectomy Syndrome: 1 person, 14.29%
- Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 1 person, 14.29%
- Erection Problems: 1 person, 14.29%
- Depression: 1 person, 14.29%
- Blood Testosterone Decreased: 1 person, 14.29%
- Apnea (temporary absence or cessation of breathing): 1 person, 14.29%
* Approximation only. Some reports may have incomplete information.
Do you take Bupivacaine and have Localised infection?
Check whether Localised infection is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Alternative drugs to, pros and cons of Bupivacaine:
- Bupivacaine (11,367 reports)
Localised infection treatments and more:
- Localised infection (23,007 reports)
COVID vaccines that are related to Localised infection:
- Localised infection in Moderna COVID Vaccine
- Localised infection in Pfizer BioNTech Covid Vaccine
- Localised infection in Johnson and Johnson Covid Vaccine
How severe was Localised infection and when was it recovered:
Expand to all the drugs that have ingredients of bupivacaine hydrochloride:
Common drugs associated with Localised infection:
- Acetylsalicylic acid: 237 reports
- Actemra: 787 reports
- Actonel: 122 reports
- Adcirca: 199 reports
- Advair hfa: 182 reports
- Advil: 114 reports
- Albuterol: 211 reports
- Alendronate sodium: 112 reports
- Allopurinol: 311 reports
- Alprazolam: 133 reports
- Ambien: 249 reports
- Amlodipine: 521 reports
- Amoxicillin: 115 reports
- Aranesp: 117 reports
- Arava: 514 reports
- Aredia: 134 reports
- Asa: 136 reports
- Aspirin: 1,181 reports
- Atenolol: 374 reports
- Ativan: 149 reports
- Augmentin: 110 reports
- Avonex: 289 reports
- Baclofen: 200 reports
- Bactrim: 162 reports
- Benadryl: 237 reports
- Calcium: 532 reports
- Carvedilol: 172 reports
- Celebrex: 466 reports
- Centrum: 108 reports
- Cephalexin: 152 reports
- Cimzia: 155 reports
- Clonazepam: 221 reports
- Clonidine: 133 reports
- Clopidogrel: 151 reports
- Cosentyx: 457 reports
- Coumadin: 343 reports
- Crestor: 215 reports
- Cymbalta: 368 reports
- Diazepam: 137 reports
- Digoxin: 179 reports
- Dilaudid: 184 reports
- Diovan: 134 reports
- Diphenhydramine hydrochloride: 157 reports
- Effexor: 144 reports
- Eliquis: 209 reports
- Enbrel: 2,526 reports
- Extraneal: 390 reports
- Fentanyl: 105 reports
- Fish oil: 240 reports
- Flexeril: 130 reports
- Flomax: 134 reports
- Flonase: 123 reports
- Fluoxetine: 115 reports
- Folic acid: 285 reports
- Forteo: 204 reports
- Fosamax: 251 reports
- Furosemide: 706 reports
- Gabapentin: 782 reports
- Glipizide: 176 reports
- Glucophage: 119 reports
- Glyburide: 129 reports
- Humalog: 460 reports
- Humira: 2,077 reports
- Humulin r: 125 reports
- Hydramine: 522 reports
- Hydrochlorothiazide: 376 reports
- Hydroxychloroquine sulfate: 254 reports
- Ibrance: 108 reports
- Ibu: 331 reports
- Ibuprofen: 341 reports
- Imbruvica: 203 reports
- Imuran: 123 reports
- Inflectra: 140 reports
- Insulin: 190 reports
- Invokana: 191 reports
- Januvia: 158 reports
- Keflex: 131 reports
- Lansoprazole: 101 reports
- Lantus: 569 reports
- Lasix: 522 reports
- Leflunomide: 470 reports
- Letairis: 226 reports
- Levaquin: 121 reports
- Levothyroxine sodium: 187 reports
- Lexapro: 117 reports
- Lipitor: 428 reports
- Lisinopril: 660 reports
- Loraz: 263 reports
- Lorazepam: 263 reports
- Losartan: 297 reports
- Lyrica: 627 reports
- Magnesium: 194 reports
- Meloxicam: 178 reports
- Metformin: 850 reports
- Methotrexate: 2,204 reports
- Methotrexate sodium: 215 reports
- Metoprolol tartrate: 171 reports
- Morphine: 325 reports
- Multivitamin: 168 reports
- Naprosyn: 117 reports
- Naproxen: 132 reports
- Neurontin: 309 reports
- Nexium: 309 reports
- Nifedipine: 131 reports
- Nitroglycerin: 183 reports
- Norco: 146 reports
- Norvasc: 213 reports
- Novolog: 184 reports
- Omeprazole: 766 reports
- Ondansetron: 134 reports
- Orencia: 333 reports
- Otezla: 159 reports
- Oxycodone: 254 reports
- Oxycontin: 251 reports
- Pantoprazole: 498 reports
- Paracetamol: 116 reports
- Pepcid: 109 reports
- Percocet: 183 reports
- Plaquenil: 528 reports
- Plavix: 279 reports
- Pomalyst: 170 reports
- Potassium: 181 reports
- Prednisolone: 200 reports
- Prednisone: 2,020 reports
- Pregabalin: 163 reports
- Prevacid: 134 reports
- Prilosec: 224 reports
- Proair hfa: 105 reports
- Prolia: 169 reports
- Protonix: 183 reports
- Prozac: 118 reports
- Ramipril: 311 reports
- Ranitidine: 152 reports
- Remicade: 399 reports
- Remodulin: 112 reports
- Revatio: 131 reports
- Revlimid: 615 reports
- Rituxan: 373 reports
- Sandostatin: 153 reports
- Sandostatin lar: 129 reports
- Seroquel: 116 reports
- Sertraline: 183 reports
- Simponi: 216 reports
- Simvastatin: 356 reports
- Singulair: 238 reports
- Spiriva: 305 reports
- Spironolactone: 203 reports
- Stelara: 231 reports
- Sulfasalazine: 487 reports
- Symbicort: 238 reports
- Synthroid: 474 reports
- Tecfidera: 106 reports
- Tracleer: 184 reports
- Tramadol: 398 reports
- Tylenol: 605 reports
- Tysabri: 289 reports
- Valsartan: 108 reports
- Velcade: 108 reports
- Ventolin: 160 reports
- Vicodin: 130 reports
- Vioxx: 157 reports
- Vitamin b12: 306 reports
- Vitamin c: 259 reports
- Vitamin d: 479 reports
- Vitamin d3: 214 reports
- Vitamins: 167 reports
- Voltaren: 123 reports
- Wellbutrin: 155 reports
- Xanax: 156 reports
- Xarelto: 196 reports
- Xeljanz: 758 reports
- Xeljanz xr: 254 reports
- Xolair: 184 reports
- Zocor: 112 reports
- Zofran: 134 reports
- Zoloft: 144 reports
- Zometa: 242 reports
- Zyrtec: 123 reports
All the drugs that are associated with Localised infection:
- Localised infection (1,335 drugs)
Common conditions associated with Localised infection:
- Acid reflux: 235 reports
- Acupuncture and pain: 408 reports
- Ankylosing spondylitis: 279 reports
- Anticoagulant therapy: 119 reports
- Antidepressant therapy: 315 reports
- Anxiety: 171 reports
- Arthritis: 196 reports
- Arthritis - rheumatoid: 4,685 reports
- Asthma: 354 reports
- Atrial fibrillation/flutter: 133 reports
- Blood cholesterol abnormal: 405 reports
- Blood cholesterol increased: 433 reports
- Blood triglycerides abnormal: 405 reports
- Blood triglycerides increased: 433 reports
- Breast cancer: 141 reports
- Bronchial asthma: 354 reports
- Chronic kidney disease: 139 reports
- Chronic lymphocytic leukaemia: 162 reports
- Chronic myeloid leukaemia: 111 reports
- Ckd: 139 reports
- Crohns: 490 reports
- Crohn's disease: 436 reports
- Depression: 315 reports
- Diabetes: 625 reports
- Diabetes mellitus: 649 reports
- Diabetes mellitus management: 657 reports
- Diabetes mellitus non-insulin-dependent: 225 reports
- Disseminated lupus erythematosus: 104 reports
- Dm: 625 reports
- Dyslipidemia: 405 reports
- Fibromyalgia: 138 reports
- Fibrositis: 131 reports
- Gastroesophageal reflux disease: 222 reports
- Gastrooesophageal reflux disease: 222 reports
- Gerd: 222 reports
- Hbp: 802 reports
- High blood cholesterol: 405 reports
- High blood pressure: 802 reports
- Hypercholesterolaemia: 405 reports
- Hyperlipidemia: 405 reports
- Hypertension: 802 reports
- Hypothyroidism: 162 reports
- Lipid disorders: 433 reports
- Lipid profile: 231 reports
- Lipid test: 433 reports
- Lipoprotein test: 405 reports
- Localised infection: 102 reports
- Metastases to bone: 124 reports
- Multiple myeloma: 711 reports
- Multiple sclerosis: 867 reports
- Neuralgia: 109 reports
- Niddm: 595 reports
- Osteoporosis: 406 reports
- Pain: 738 reports
- Pain management: 734 reports
- Plasma cell myeloma: 711 reports
- Preventive health care: 109 reports
- Primary pulmonary hypertension: 628 reports
- Psoriasis: 1,017 reports
- Psoriatic arthropathy: 846 reports
- Pulmonary arterial hypertension: 628 reports
- Pulmonary hypertension: 244 reports
- Pyrosis: 222 reports
- Ra: 4,685 reports
- Renal failure chronic: 101 reports
- Rheumatoid arthritis: 4,685 reports
- Sleep disorders: 143 reports
- Sleep issues: 123 reports
- Spondylitis: 279 reports
- Stress and anxiety: 171 reports
- Type 2 diabetes: 595 reports
- Type 2 diabetes mellitus: 617 reports
- Ulcerative colitis: 195 reports
- Vitamin supplementation: 125 reports
All the conditions that are associated with Localised infection:
- Localised infection (810 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on bupivacaine hydrochloride (the active ingredients of Bupivacaine) and Bupivacaine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Xyzal and Hormone Level Abnormal - 2 seconds ago
- Enlarged Prostate and Transient Ischaemic Attack - 5 seconds ago
- Paroxysmal Nocturnal Haemoglobinuria and Pancreatic Carcinoma - 6 seconds ago
- Cefuroxime and Flank Pain - 8 seconds ago
- Lioresal and Blood Albumin Decreased - 18 seconds ago